Department of Innovative Drug Discovery and Development Division of Strategic Planning and Evaluation

The Division of Strategic Planning and Evaluation, which acts as the headquarters of drug discovery support network, has a system in place to provide accurate and effective support for each stage of the development: from target verification to preclinical research in drug discovery R&D originating in academia. Drug discovery coordinators with extensive R&D experience at pharmaceutical companies strongly support drug discovery research through the evaluation of drug discovery seeds, the formulation of intellectual property strategies, project management, and transfer of research results to industry. The division also supports drug development, from search for drug discovery target to clinical research, targeting infectious diseases and rare/intractable.

• Research Program on Emerging and Re-emerging Infectious Diseases
• Practical Research Project for Rare / Intractable Diseases
• Infrastructure Program for Drug Discovery Seeds Development
• Drug Discovery Support Network (DDSN)
• Project Promoting Support for Drug Discovery
• The iD3 Booster
• The iD3 Navi
• The iD3 Technology Archive
• Drug-Discovery Innovation and Screening Consortium (DISC)
• Development of a Drug Discovery Informatics System
• Support Program for Orphan drug prior to the Designation

• Research Program on Hepatitis

Contact

Department of Innovative Drug Discovery and Development
(East Japan Office) Tel : +81-3-3516-6181
(West Japan Office) Tel : +81-6-6372-1771